Search filters

List of works by Debashis Sarker

A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors

scientific article published on 07 August 2018

ADI-PEG 20 Plus Best Supportive Care versus Placebo Plus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma

scientific article published on 5 April 2018

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

scientific article published on 29 August 2019

Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?

scientific article

Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents

scientific article published on 21 September 2018

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem.

scientific article

FOLFIRINOX - a new paradigm in the treatment of pancreatic cancer

scientific article published on 10 September 2014

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

scientific article published on 01 October 2019

First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors

scientific article

First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

scientific article published on 01 September 2018

Functional imaging techniques in hepatocellular carcinoma ⬇️

scientific article published on March 21, 2012

Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure

scientific article published on 28 December 2018

Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Co-Infection: A Case Report.

scientific article published on 22 June 2017

Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.

scientific article published on 13 July 2017

Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours.

scientific article published on July 2016

Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?

scientific article

MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial

scientific article published on 01 May 2020

Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?

scientific article

NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progre

scientific article published on 05 February 2020

P-098Prognostic significance of comorbidities in elderly patients with Hepatocellular carcinoma (HCC) treated with Transarterial Chemoembolization: a Single Centre Experience.

scientific article

P-115Weight loss during 1st-line chemotherapy for upper gastrointestinal malignancies (UGI) may impact survival and access to further treatment lines.

scientific article

PAK4 pathway as a potential therapeutic target in pancreatic cancer.

scientific article

PD-021A single centre experience of the prognostic variables in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization.

scientific article published on 21 June 2016

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

scientific article published on 03 June 2018

Pharmacodynamic Biomarker Development for PI3K Pathway Therapeutics

scientific article

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

scientific article published on 24 September 2020

Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets

scientific article

Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma

scientific article published on 05 August 2014

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

scientific article published on 19 April 2022

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

scientific article published on 18 August 2021

Paulina is supported by:

About Paulina

Help